Histopathology of the ductus arteriosus after PGE1 treatment.

Histopathology of the ductus arteriosus after PGE1 treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Histopathology of the ductus arteriosus after PGE1 treatment. Abstract Text:

S Tsubata,I Hashimoto,F Ichida,A Miyazaki,T Okada,A Murakami,H Morita,K Fukahara,

Histopathology of the ductus arteriosus after PGE1 treatment. Publishing Authors By Initials

S Tsubata,I Hashimoto,F Ichida,A Miyazaki,T Okada,A Murakami,H Morita,K Fukahara,

For similar cardiovascular diseases: cardiovascular abnormalities: vascular malformations: pulmonary atresia research abstracts see: cardiovascular diseases: cardiovascular abnormalities: vascular malformations: pulmonary atresia research

PUBMED ID PMID:

MEDLINE DATE: 1995 Mar-Apr

Histopathology of the ductus arteriosus after PGE1 treatment. Journal Published:

PUBLICATION TYPE: Letter

Journal: Pediatric cardiology

VOLUME: 16

Page Numbers: 101

Journal Abbreviation: Pediatr Cardiol

ISSN: 0172-0643

DAY: 20

MONTH: 02

YEAR: 2008

Histopathology of the ductus arteriosus after PGE1 treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8003849

Histopathology of the ductus arteriosus after PGE1 treatment. Keywords Mesh Terms:

KEYWORDS: Pulmonary Atresia

MESH TERMS: pathology

Chemical & Substance for Abstract: Histopathology of the ductus arteriosus after PGE1 treatment. Information

Substance Name: Alprostadil

Registry Number: 745-65-3

Grant and Affiliation Information for Histopathology of the ductus arteriosus after PGE1 treatment.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pediatr Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Histopathology of the ductus arteriosus after PGE1 treatment Related Publications

• Aplasia of semilunar valve leaflets: two case reports and developmental aspects.
• Cardiac development.
• Cardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: Correlation with abnormal epicardial development.
• Coarctation of the aorta in the syndrome of absent pulmonary valve with ventricular septal defect.
• Congenital polyvalvular disease: a review.
• Development of the cardiac conduction system and the possible relation to predilection sites of arrhythmogenesis.
• Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling.
• Epicardium-derived cells are important for correct development of the Purkinje fibers in the avian heart.
• Epicardium-derived cells in development of annulus fibrosis and persistence of accessory pathways.
• Histopathology of the ductus arteriosus after PGE1 treatment.
• Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema.
• Morphogenetic differences of secundum atrial septal defects.
• OP01.01: Altered FOXC2 and PDGF-B expression relates to abnormal smooth muscle cell formation surrounding enlarged jugular lymphatic sacs in fetuses with nuchal edema.
• Origin, Fate, and Function of Epicardium-Derived Cells (EPCDs) in Normal and Abnormal Cardiac Development.
• PDGF-B signaling is important for murine cardiac development: Its role in developing atrioventricular valves, coronaries, and cardiac innervation.
• Periostin expression by epicardium-derived cells is involved in the development of the atrioventricular valves and fibrous heart skeleton.
• Pitx2: a challenging teenager.
• Transcription factor Sp3 knockout mice display serious cardiac malformations.